PRODUCT CHARACTERISTICS ASSOCIATED WITH IN VIVO EXPANSION OF ANTI-CD19 CAR T CELLS IN PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL (AXI-CEL)

Journal article

Peer reviewed

S.S. Neelapu, J.M. Rossi, F.L. Locke, A. Xue, M. Better, X. Zhang, A. Ghobadi, L.J. Lekakis, D. Miklos, C.A. Jacobson, …

Hematological oncology, Vol.35(S2), pp.262-263

2017-06

Metrics

46 Record Views

Title: PRODUCT CHARACTERISTICS ASSOCIATED WITH IN VIVO EXPANSION OF ANTI-CD19 CAR T CELLS IN PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL (AXI-CEL)
Creators: S.S. Neelapu - The University of Texas MD Anderson Cancer Center
J.M. Rossi - Kite
F.L. Locke - Moffitt Cancer Center
A. Xue - Kite
M. Better - Kite
X. Zhang - Kite
A. Ghobadi - Washington University in St. Louis
L.J. Lekakis - University of Miami
D. Miklos - Stanford University
C.A. Jacobson - Harvard University
I. Braunschweig - Albert Einstein College of Medicine
O. Oluwole - Vanderbilt University
T. Siddiqi - City Of Hope National Medical Center
Y. Lin - Mayo Clinic
J. Timmerman - University of California, Los Angeles
P.M. Reagan - University of Rochester Medical Center
L. Navale - Kite
W.Y. Go - Kite
J. Wiezorek - Kite
A. Bot - Kite
Publication Details: Hematological oncology, Vol.35(S2), pp.262-263
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031713234102976